The International Cooperation Department of the China Securities Regulatory Commission issued a filing notice on the “full circulation” of unlisted domestic shares of Yiming Angke Biomedical Technology Co., Ltd. The seven shareholders of the company intend to convert a total of 14,114,006 domestic unlisted shares into overseas listed shares and list them for circulation on the Hong Kong Stock Exchange.

Zhitongcaijing · 03/13 09:25
The International Cooperation Department of the China Securities Regulatory Commission issued a filing notice on the “full circulation” of unlisted domestic shares of Yiming Angke Biomedical Technology Co., Ltd. The seven shareholders of the company intend to convert a total of 14,114,006 domestic unlisted shares into overseas listed shares and list them for circulation on the Hong Kong Stock Exchange.